News Quantified

FIXX – homology medicines, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million [Yahoo! Finance]

Homology Medicines Declares Distribution to Common Stockholders

Kuehn Law Encourages FIXX, SCTL, EVRI, and GRPH Investors to Contact Law Firm

HOMOLOGY MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Homology Medicines, Inc. - FIXX

Q32 Bio Announces Publication of Preclinical Data in Molecular Therapy Demonstrating the Therapeutic Potential of Tissue-Targeted Complement Inhibitor ADX-097 for Complement-Mediated Diseases [Yahoo! Finance]

-9.3%

MISS

-1.3%

BEAT

Form 8-K Q32 Bio Inc. For: Mar 25

Form 8-K/A Homology Medicines, Inc. For: Mar 20

Form 8-K Homology Medicines, Inc. For: Mar 20

Form 8-K Homology Medicines, Inc. For: Mar 15

Form SCHEDULE 13G Homology Medicines, Inc. Filed by: ADAR1 Partners, LP

Top News Gainers

3/18 Form 4 Homology Medicines, Inc. For: Mar 17 Filed by: Kelly Timothy P 11.1%

1/31 Form 4 Homology Medicines, Inc. For: Jan 29 Filed by: Deerfield Healthcare Innovations Fund, L.P. 7.1%

3/26 Homology Medicines Inc (NASDAQ: FIXX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 6.8%

12/13 Form 4 Homology Medicines, Inc. For: Dec 11 Filed by: Seymour Albert 5.9%

3/12 Q4/2019 12/31/2019 EPS -0.550 ZacksConsensus -0.720 ActVsEst 0.170 - Beat 5.9%

5/1 Form SC 13D/A Homology Medicines, Inc. Filed by: Flynn James E 5.1%

11/12 Homology Medicines Reports Third Quarter 2019 Financial Results and Recent Highlights 5.1%

7/17 Homology Medicines Inc (NASDAQ: FIXX) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 5.0%

7/15 Homology Medicines Appoints Alise Reicin, M.D., to the Board of Directors 5.0%

10/21 Homology Medicines Presents Data from Investigational PKU and MLD Gene Therapy Programs that Demonstrate Preclinical Proof-of-Concept for Potential One-Time Therapies 4.8%

Top News Decliners

3/14 Homology Medicines Inc (NASDAQ: FIXX) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $34.00 price target on the stock. -16.1%

1/4 Homology Medicines Inc (NASDAQ: FIXX) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -5.5%

2/20 Homology Medicines to Participate in Upcoming Investor and Scientific Conferences -5.0%

2/13 Homology Medicines Presents New Data Characterizing AAVHSCs as Potential Gene Therapies for Nervous System Disorders -4.7%

12/17 Homology Medicines Announces Encouraging Initial Clinical Data from its pheNIX Gene Therapy Trial for PKU -4.6%

3/6 Homology Medicines Inc (NASDAQ: FIXX) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -4.5%

7/1 Platelet BioGenesis Appoints Biotech Industry Veteran Sam Rasty, Ph.D., as President and Chief Executive Officer -4.2%

3/12 Form S-3ASR Homology Medicines, Inc. -3.9%

12/30 Form SC 13D/A Homology Medicines, Inc. Filed by: Flynn James E -3.8%

2/24 Homology Medicines Inc (NASDAQ: FIXX) is now covered by analysts at Chardan Capital. They set a "buy" rating and a $34.00 price target on the stock. -3.4%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day